Abstract

Autoimmune polyendocrinopathies are traditionally divided into two distinct syndromes, autoimmune polyendocrine syndrome type 1 and 2 (APS-1 and -2). The first is a monogenic disease caused by mutations in the autoimmune regulator (AIRE) gene, the second is associated with variants in immune genes, in particular certain major histocompatibility complex genotypes, but also to coding variants in AIRE. Even if each syndrome have distinct features, there is also considerably overlap in phenotypes and circulating autoantibodies. In this overview recent progress in the understanding of pathogenic mechanisms and clinical features of APS-1 and -2 is summarized highlighting the role of AIRE in both conditions.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.